Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

First-line

Clinical trials for First-line explained in plain language.

Never miss a new study

Get alerted when new First-line trials appear

Sign up with your email to follow new studies for First-line, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1
Sort by
  • Can a new drug combo boost remission in aggressive lymphoma?

    Disease control Recruiting now

    This trial tests whether adding orelabrutinib to a standard chemotherapy regimen (Pola-R-CHP) can improve outcomes for people with intermediate- to high-risk diffuse large B-cell lymphoma (DLBCL) who have not yet received treatment. The study will enroll about 30 adults with conf…

    Matched conditions: FIRST-LINE

    Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Disease control

    Last updated Aug 23, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space